ARIMIMED 1 - Deus Medical

In 1995, Anastrozole ( another well known name - "arimidex" was approved for medical use, marking a significant result in breast cancer treatment. The medication provides a method to lower estrogen levels and is considered an important treatment option, for hormone sensitive breast cancer, in postmenopausal women who have previously taken tamoxifen. Developed by Zeneca Pharmaceuticals, this third generation aromatase inhibitor functions by inhibiting the enzyme that produces estrogen in the body.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about ARIMIMED 1 by Deus Medical, consult with your doctor or healthcare professional.